KVUE — Kenvue Inc. stock price, charts and financials

QT46Kenvue Inc.

Kenvue Inc. (NYSE: KVUE) is a Consumer Defensive company in the Household & Personal Products industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
19.07
-0.15-0.81%
OverviewShort InterestFilings
KVUEQT46Kenvue Inc.·NYSE
19.07-0.81%
TA
Loading chart...
Screen all →
KMB-1.08%$108.50EL-1.75%$86.80CHD+0.09%$103.33CL-0.29%$93.00CLX+1.78%$107.02UL-0.49%$62.65ELF-2.94%$95.59REYN-0.70%$26.34
Snapshot
IndexS&P 500P/E22.10EPS (ttm)0.87Insider Own1.66%Shs Outstand1.92BPerf Week-0.05%
Market Cap36.92BForward P/E15.25EPS next Y1.26Insider Trans-0.13%Shs Float1.92BPerf Month0.26%
Enterprise Value44.29BPEG1.26EPS next Q-Inst Own-Short Float3.21%Perf Quarter8.52%
Income1.66BP/S2.40EPS this Y40.86%Inst Trans-Short Ratio3.07Perf Half Y6.42%
Sales15.41BP/B3.50EPS next Y5.32%ROA6.20%Short Interest61.56MPerf YTD11.48%
Book/sh-P/C15.88EPS next 5Y4.14%ROE15.58%52W High21.78 -12.43%Perf Year-10.31%
Cash/sh-P/FCF17.44EPS past 3/5Y-11.05% -ROIC10.07%52W Low13.91 37.16%Perf 3Y-19.54%
Dividend Est.0.84 (4.40%)EV/EBITDA13.99Sales past 3/5Y0.39% 0.89%Gross Margin58.19%Volatility3.67% 2.50%Perf 5Y-
Dividend TTM0.83 (4.35%)EV/Sales2.87EPS Y/Y TTM57.41%Oper. Margin19.52%ATR (14)0.51Perf 10Y-
Dividend Ex-DateAug 12, 2026Quick Ratio0.71Sales Y/Y TTM-1.05%Profit Margin10.76%RSI (14)51.43Recom2.71
Dividend Gr. 3/5Y-Current Ratio1.01EPS Q/Q33.33%SMA200.09%Beta0.11Target Price19.00
Payout0.66%Debt/Eq0.80Sales Q/Q4.49%SMA502.77%Rel Volume0.68Prev Close19.23
Employees22,000LT Debt/Eq0.66EarningsNov 02SMA2009.14%Avg Volume21.18MPrice19.07
IPO DateMay 04, 2023Option/ShortYes / YesEPS/Sales Surpr.22.10% 1.67%Net Debt/EBITDA2.33Volume14,323,642Change-0.81%
Analyst Ratings
DateActionAnalystRatingTarget
Jul-21-26ReiteratedBarclaysEqual Weight$18 → $19
Jul-16-26ReiteratedUBSNeutral$19 → $20
Apr-14-26ReiteratedBarclaysEqual Weight$17 → $18
Feb-18-26ReiteratedUBSNeutral$17 → $19
Feb-18-26ReiteratedCanaccord GenuityHold$15 → $18
Jan-30-26DowngradeJefferiesBuy → Hold$23 → $18
Oct-29-25DowngradeCanaccord GenuityBuy → Hold$29 → $15
Oct-28-25ReiteratedEvercore ISIIn Line$18
Oct-27-25ReiteratedJefferiesBuy$27 → $23
Oct-24-25ReiteratedDeutsche BankHold$20 → $18
Latest News
Aug-07-26
Aug-07-2608:45AM
Kimberly-Clark: 'Buy' This Undervalued Dividend King Before Kenvue Closesseekingalpha.com
Aug-06-26
Aug-06-2602:58PM
Kenvue Stock Falls 2.7% as Growth Arrives With Thinner Marginsgurufocus.com
02:41PM
KVUE Q2 Earnings Miss Estimates as Margins Narrows, Sales Risezacks.com
11:37AM
Kenvue second quarter results fall short of expectations, sending shares lowerproactiveinvestors.com
09:21AM
Kenvue (KVUE) Lags Q2 Earnings and Revenue Estimateszacks.com
07:47AM
Kenvue misses quarterly estimates as inflation, tariffs squeeze marginsreuters.com
07:38AM
Kenvue Posts Higher Profit, Sales as Turnaround Continueswsj.com
06:45AM
Kenvue Reports Second Quarter 2026 Resultsbusinesswire.com
Aug-05-26
Aug-05-2603:43AM
Cetera Investment Advisers Trims Holdings in Kenvue Inc. $KVUEdefenseworld.net
Aug-04-26
Aug-04-2601:04PM
Kimberly-Clark Q2 Earnings: More Challenges, But The Market Is Looking ElsewhereSeekingAlpha
Jul-31-26
Jul-31-2602:26PM
Kenvue's Q2 Earnings Coming Up: Here's What Lies Ahead of the Stockzacks.com
Jul-29-26
Jul-29-2611:41AM
Kenvue Benefits From Consumer Health Trends and Margin Expansionzacks.com
11:41AM
Is Kenvue Stock Attractive After Margin Gains and Deal Uncertaintyzacks.com
11:41AM
Kenvue's Brand Strength and Growth Drivers Shape Its Future Outlookzacks.com
06:45AM
Kenvue Increases Quarterly Cash Dividendbusinesswire.com
Company

Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands like Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corporate headquarters in Skillman, New Jersey, and operates as a subsidiary of Johnson & Johnson.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/28/2025
FY 2024
12/29/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
Total Revenue15,40815,12415,455—————
Cost of Goods Sold Incl. D&A6,4426,3326,496—————
Gross Profit8,9668,7928,959—————
Selling, General and Administrative Excl. Other4,5006,0886,027—————
Research and Development843820—————
Other Operating Expense1,380-3821,091—————
Operating Income3,0082,7041,841—————
Interest Expense376379431—————
Unusual Expense
————————
Non-Operating Income (Expense)-409-3265—————
Net Income Before Taxes2,2231,9991,415—————
Income Taxes565529385—————
Consolidated Net Income1,6581,4701,030—————
Net Income From Continuing Operations1,6581,4701,030—————
Net Income1,6581,4701,030—————
EPS (Recurring)0.870.770.54—————
EPS (Basic, Before Extraordinaries)0.870.770.54—————
EPS (Diluted)0.870.760.54—————
EBITDA3,1662,9352,468—————
Other After Tax Adjustments
————————
Stock Option Compensation Expense
————————
Price To Earnings Ratio21.9322.6239.87—————
Price To Sales Ratio2.382.182.67—————
Gross Margin58.1958.1357.97—————
Operating Margin19.5217.8811.91—————
Net Margin10.769.726.66—————
Shares Outstanding1,9201,9171,915—————
Market Capitalization36,62432,95341,230—————
Operating Lease Expense
————————
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
$25.33$22.16$18.99$15.82$12.65● Close Price0.00M27.75M55.49M83.24M110.99MUSD Trades VolumeAugSepOctNovDec2026FebMarAprMayJunJulAug
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Dasgupta AnindyaGroup President APACJul 31 '26Option Exercise0.0016,419016,419Aug 04
Howlett HeatherCFO & CAOJun 10 '26Sale18.113,70066,98929,288Jun 12
Curado Gomes de Lemos LeonardoGroup President LATAMMay 01 '26Option Exercise0.0024,248024,248May 26
Orlando MatthewGeneral CounselMay 08 '26Sale17.6638,491679,6910May 12
Stevens MeredithChief Operations OfficerMar 10 '26Option Exercise0.005,169094,877Mar 12
Alvarado LuaniChief People OfficerMar 10 '26Option Exercise0.004,222062,797Mar 12
Lawson CarltonGroup President EMEA & LAMar 10 '26Option Exercise0.006,1580111,415Mar 12
Lawson CarltonGroup President EMEA & LAMar 05 '26Option Exercise0.007,7360105,257Mar 09
Alvarado LuaniChief People OfficerMar 05 '26Option Exercise0.004,289061,365Mar 09
Stevens MeredithChief Operations OfficerMar 05 '26Option Exercise0.006,178092,224Mar 09
Howlett HeatherVP & Chief Accounting OfficerMar 05 '26Option Exercise0.002,723033,921Mar 09
Howlett HeatherVP & Chief Accounting OfficerMar 03 '26Option Exercise0.001,534031,725Mar 04
Stevens MeredithChief Operations OfficerFeb 13 '26Option Exercise0.0028,040090,862Feb 18
Alvarado LuaniChief People OfficerFeb 13 '26Option Exercise0.0015,942060,722Feb 18
Lawson CarltonGroup President EMEA & LAFeb 13 '26Option Exercise16.5239,426651,36597,521Feb 18
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.